{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:32:26Z","timestamp":1770481946145,"version":"3.49.0"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":3888,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>One hundred consecutive patients with malignant lymphoma treated with high\u2010dose chemotherapy and autologous stem cell transplantation, followed at least 1 yr post\u2010transplant, are reported, 68 with non\u2010Hodgkin's lymphoma and 32 with Hodgkin's disease. At transplant, 23 patients were in first remission, 69 in later chemosensitive disease and 8 were chemotherapy resistant. Based on previous treatment and stem\u2010cell source, the patients were subdivided into 3 cohorts: BMT<jats:sup>1<\/jats:sup>: bone\u2010marrow harvest and transplant after \u22653 treatment regimens (38 patients); BMT<jats:sup>2<\/jats:sup>: bone marrow harvest and transplant after less than 3 treatment regimens (24 patients); PBSCT: peripheral\u2010blood stem cell transplant (38 patients, 5 of these with CD34+ cell selected PBSC). The 4\u2010yr survival and progression\u2010free survival of all patients was 45 and 40%, respectively. Forty\u2010one patients have died, 27 of lymphoma, evenly distributed in the cohorts. Fourteen treatment\u2010related deaths occurred, 13 of these in the BMT<jats:sup>1<\/jats:sup>cohort, significantly more than in the other cohorts (<jats:italic>p<\/jats:italic>=0.001). In univariate survival analysis cohort, age, disease status at transplant and number of previous treatment regimens were significant. In multivariate survival analysis cohort, age and sex were independently significant, women having a shorter survival. The patients transplanted with unselected PBSC had significantly shorter duration of pancytopenia and hospital stay than the otherwise comparable BMT<jats:sup>2<\/jats:sup>patients, but their progression\u2010free survival was identical. We confirm that high\u2010dose therapy with autologous stem cell transplant from blood or bone marrow in not\u2010too\u2010heavily pretreated patients is a safe procedure but will cure only half the patients.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1998.tb01081.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T09:34:17Z","timestamp":1279445657000},"page":"173-182","source":"Crossref","is-referenced-by-count":4,"title":["BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem\u2010cell source and previous treatment"],"prefix":"10.1111","volume":"61","author":[{"given":"C. H.","family":"Geisler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M\u00f8rk","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. S.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Dalh","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dickmeiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ersb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Myhre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Ravn","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Thing","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pedersen\u2010Bjergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199209067606"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.588"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92411-L"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90795-5"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood.V77.8.1717.1717","article-title":"Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma","volume":"8","author":"Berenson RJ","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91552-3"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1323"},{"issue":"1","key":"e_1_2_1_10_2","first-page":"536a","article-title":"ABMT for lymphomas \u2013 a 15 year European Bone Marrow Transplant Registry experience of 3325 patients","volume":"84","author":"Fielding AK","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.1.1992.1.329"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non\u2010parametric estimations from incomplete observations","volume":"153","author":"Kaplan E.","year":"1958","journal-title":"J Am Stat Soc"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox DR.","year":"1972","journal-title":"J Royal Stat Soc B"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400809"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1131"},{"issue":"1","key":"e_1_2_1_17_2","first-page":"467a","article-title":"Intensified induction phase including autologous peripheral stem cell transplantation does not improve response rate and survival in lymphoma with at least 2 adverse prognostic factors when compared to ACVB","volume":"88","author":"Gisselbrecht C.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705013361804"},{"issue":"1","key":"e_1_2_1_19_2","first-page":"180","article-title":"Autologous stem cell transplantation (ASCT) in first remission improves outcome in adult patients with lymphoblastic lymphoma (LBL): results from a randomized trial the European for Blood and Marrow Transplantation (EBMT) and the UK Lymphoma Group (UKLG)","volume":"21","author":"Santini G.","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.925"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706113162401"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1621"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1182\/blood.V83.5.1161.1161","article-title":"Autologous transplantation for Hodgkin's disease: coming of age","volume":"83","author":"Bierman PJ","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood.V81.5.1137.1137","article-title":"The place of high\u2010dose BEAM therapy and autologous bone\u2010marrow transplantation in poor\u2010risk Hodgkin's disease. A single\u2010center eight\u2010year study of 155 patients","volume":"81","author":"Chopra R.","year":"1993","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_25_2","first-page":"152a","article-title":"High\u2010dose therapy and autologous bone marrow transplantation for adult patients with primary refractory Hodgkin's disease \u2013 30% of patients are progression\u2010free at 5 years: data from 290 patients reported to the EBMT","volume":"19","author":"Sweetenham J.","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.9.2465"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.7.1358"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.445"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(91)90126-E"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.1990.8.5.784","article-title":"Autologous bone marrow transplantation in B\u2010cell non\u2010Hodgkin's lymphoma: very low treatment\u2010related mortality in 100 patients in sensitive relapse","author":"Freedman AS","year":"1990","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700713"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90536-X"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.661"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1182\/blood.V85.7.1936.bloodjournal8571936","article-title":"Blood\u2010derived autografts collected during granulocyte\u2010colony stimulating factor\u2010enhanced recovery are enriched with early Thy\u20101+ hematopoietic progenitor cells","volume":"85","author":"Haas R.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111283252201"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08332.x"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V91.1.331","article-title":"Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources","volume":"91","author":"Leonard BM","year":"1998","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_38_2","first-page":"281a","article-title":"Presence of clonal cells in all stem cell enriched grafts in multiple myeloma","volume":"90","author":"Thunberg U.","year":"1997","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_39_2","first-page":"281a","article-title":"A phase\u2010III study evaluating CD34+ selected versus unselected autologous peripheral blood progenitor cell transplantation for patients with advanced multiple myeloma. Engraftment results","volume":"90","author":"Schiller G.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_1_40_2","first-page":"981","article-title":"High\u2010dose therapy and autologous bone marrow transplantation for intermediate and high\u2010grade non\u2010Hodgkin's lymphoma in patients 55 years and older: results from the European Group for Blood and Marrow Transplantation","volume":"14","author":"Sweetenham JW","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400795"},{"issue":"1","key":"e_1_2_1_42_2","first-page":"178","article-title":"The intensification of BEAM conditioning does not influence event\u2010free and overall survival of patients transplanted for non\u2010Hodgkin's malignant lymphomas","volume":"21","author":"Trneny M.","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700682"},{"issue":"1","key":"e_1_2_1_44_2","first-page":"166","article-title":"Double autologous stem cell transplantation in refractory and early disseminated relapse from Hodgkin's disease","volume":"21","author":"Brice P.","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700646"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1998.tb01081.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1998.tb01081.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T02:27:07Z","timestamp":1740277627000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1998.tb01081.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1111\/j.1600-0609.1998.tb01081.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1998.tb01081.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}